Back to VA Vestmark Advisory Solutions, Inc.

TXGTXG

Showing 8 of 16 quarters

Position history for VAVestmark Advisory Solutions, Inc.'s holdings in 10x Genomics, Inc.

Yes. Vestmark Advisory Solutions holds 131,407 shares of TXG (10x Genomics), worth $11.9M, as of its Q3 2026 13F filing. It reduced the position by 81,470 shares (-38.3%) from Q2 2026. Vestmark Advisory Solutions has held TXG since Q4 2023, across 12 quarterly 13F filings. TXG is 0.1% of Vestmark Advisory Solutions' reported 13F portfolio.

Current Value

$11.9M

Current Shares

131,407

Total Value Change

+$6.9M

Total Shares Change

-164,132

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
131,407
-38.3%
$11.9M0.1%$90.36
0
2026-Q2
Decreased
212,877
-15.2%
$8.2M0.1%$38.34
0
2026-Q1
Decreased
251,030
-7.3%
$5.3M0.1%$21.23
0
2025-Q4
Decreased
270,668
-1.4%
$4.4M0.1%$16.31
0
2025-Q3
Decreased
274,440
-55.4%
$3.2M0.1%$11.69
0
2025-Q2
Increased
615,294
+109.7%
$7.1M0.1%$11.58
53
2025-Q1
Decreased
293,400
-0.7%
$2.6M0.1%$8.73
0
2024-Q4
Increased
295,539
+19.1%
$5M0.2%$14.36
38

Optional analytics helps us improve. How it’s used